2025-05-30 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc (HIMS) based on the provided data, formatted in English.

**Hims & Hers Health Inc (HIMS) Analysis**

**0. Overview**

This report analyzes the performance of Hims & Hers Health Inc. (HIMS) relative to the S&P 500 (VOO), examining its stock performance, market indicators, recent news, and financial data to provide a comprehensive overview.

**1. Performance Relative to S&P 500 (VOO)**

*   **Ticker:** HIMS
*   **Company Description:** Hims & Hers Health Inc. is a telehealth company that provides personalized health and wellness solutions directly to consumers.
*   **HIMS Cumulative Return:** 264.52%
*   **VOO (S&P 500) Cumulative Return:** 49.19%
*   **Absolute Divergence:** 215.3
*   **Divergence Range:** (Max: 294.1, Min: -92.7)
*   **Relative Divergence:** 79.6

**Analysis:** HIMS has significantly outperformed the S&P 500, with a cumulative return substantially higher. The relative divergence of 79.6 indicates that HIMS's performance is in the upper quartile compared to its historical range relative to the S&P 500. It means the stock is outperforming VOO, and based on historical data, it is near the high end of its relative performance range.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha  | Beta   | Cap(B) |
| :----------- | :------ | :----- | :----- | :----- | :------- |
| 2019-2021  | -46.0%  | 51.0%  | -89.0% | 0.0    | 1.5      |
| 2020-2022  | -15.0%  | 72.1%  | -20.0% | -0.0   | 1.5      |
| 2021-2023  | -51.0%  | 72.1%  | -67.0% | -0.1   | 2.0      |
| 2022-2024  | 127.0%  | 78.4%  | 111.0% | -0.2   | 5.5      |
| 2023-2025  | 260.0%  | 78.4%  | 230.0% | -0.1   | 11.9     |

**Analysis:**  The table reveals a volatile history.  Early periods (2019-2023) show negative CAGR and substantial Maximum Drawdown (MDD), indicating significant risk. Alpha is consistently negative, and Beta is near zero or slightly negative, indicating the stock is weakly correlated, or even inversely correlated with the market. The last two periods (2022-2025) demonstrate strong positive performance with high CAGR and positive Alpha, suggesting a recent shift towards outperformance.  Market capitalization has also grown significantly, especially in the last year.

**2. Recent Stock Price Movements**

*   **Current Price:** $52.40
*   **Last Market Data:**
    *   Price: $52.4
    *   Previous Close: $53.34
    *   Change: -$1.76
*   **5-Day Moving Average:** $53.49
*   **20-Day Moving Average:** $53.83
*   **60-Day Moving Average:** $38.63

**Analysis:** The current price is slightly below the 5-day and 20-day moving averages, suggesting a short-term downward trend. The price change from the previous close also confirms this. The 60-day moving average is significantly lower, implying a longer-term upward trend overall, despite the recent pullback.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 51.28 (Neutral)
*   **PPO:** -3.28 (Potentially Oversold)
*   **Hybrid Signal:** cash_70%_Sell 0.6% of holdings (9 shares - Caution - MRI:0.37)
*   **20-Day Relative Divergence Change:** -9.5 (Negative - Short-Term Decline)
*   **Expected Return:** -10.3% (Long-Term, Relative to S&P 500)

**Analysis:** The MRI indicates low market risk. The RSI is near neutral.  The negative PPO suggests the stock might be oversold in the short term and could be due for a rebound. The Hybrid Signal suggests caution, recommending a higher cash position. The recent decline in relative divergence supports the short-term downward trend. The negative expected return suggests that, based on the model, HIMS is projected to underperform the S&P 500 over the next 2 years. The negative change in price suggests some downside momentum.

**4. Recent News & Significant Events**

*   **[2025-05-29]:** Hims & Hers Health Inc (HIMS) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-05-28]:** Analysts are discussing Hims & Hers Health Inc's (HIMS) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-05-26]:** Hims & Hers Health Inc (HIMS)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-27]:** Market experts highlight both risks and opportunities for Hims & Hers Health Inc (HIMS), advising investors to monitor recent news and company announcements.

**Analysis:** The news indicates increased attention on HIMS due to business developments, regulatory changes, and market events. Volatility is noted, and investors are advised to monitor company announcements. This underscores the need for careful analysis of the company's fundamentals.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue |
| :--------- | :--- | :------ |
| 2025-05-05 | 0.22 | 0.59 B$ |
| 2024-11-04 | 0.35 | 0.40 B$ |
| 2024-08-05 | 0.06 | 0.32 B$ |
| 2024-05-06 | 0.05 | 0.28 B$ |
| 2025-05-05 | 0.05 | 0.28 B$ |

**Analysis:** The earnings data shows a general trend of increasing revenue and fluctuating EPS. Revenue has consistently increased quarter-over-quarter.
**6. Financial Information:**

Revenue and Profitability:

| Quarter      | Revenue | Profit Margin |
| :----------- | :------ | :------------ |
| 2025-03-31 | $0.59B | 73.50%      |
| 2024-12-31 | $0.48B | 76.81%      |
| 2024-09-30 | $0.40B | 79.16%      |
| 2024-06-30 | $0.32B | 81.30%      |
| 2024-03-31 | $0.28B | 82.36%      |

Capital and Profitability:

| Quarter      | Equity  | ROE   |
| :----------- | :------ | :---- |
| 2025-03-31 | $0.55B | 9.01% |
| 2024-12-31 | $0.48B | 5.46% |
| 2024-09-30 | $0.44B | 17.18% |
| 2024-06-30 | $0.36B | 3.67% |
| 2024-03-31 | $0.34B | 3.23% |

**Analysis:** Revenue shows strong growth quarter over quarter. The Profit Margin has decreased steadily in the last year. Equity has also increased steadily quarter-over-quarter. ROE has fluctuated, with a high in 2024-09-30, but generally trending upwards.

**7. Overall Summary**

Hims & Hers Health Inc. (HIMS) has significantly outperformed the S&P 500 in the long term, but faces some short-term headwinds.  The recent price action, combined with market risk indicators, suggests a need for caution. Revenue and Equity are growing but Profit Margin has decreased steadily in the last year. Despite the positive historical outperformance, a higher cash position and careful monitoring of news and announcements are advised, given the observed volatility and expected underperformance relative to the S&P 500 over the next 2 years. Also, note that news suggest the company has major business developments.
